Shenzhen Sangel Venture Capital Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 3

Professionals

  • Investments
  • 72

  • Portfolio
  • 44

  • Exits
  • 12

Exits

Shenzhen Sangel Venture Capital General Information

Company Description

Founded in 2009, Shenzhen Sangel Venture Capital is a venture capital firm headquartered in Shenzhen, China. The firm seeks to invest in biomedical companies with a focus on life science, biotech, biopharma, medical devices, and digital health sectors.

Business Details

Website
www.sangelvc.com
Year Founded
2009
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Accelerator/Incubator
Corporate Office
  • 2401/2402, Shenzhen Bay Venture Capital Building
  • Nanshan District
  • Shenzhen
  • China
+86 0755

Shenzhen Sangel Venture Capital Investments (72)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
OxTium 25-Jan-2024 Early Stage VC Decision/Risk Analysis Generating Revenue
Proviva Therapeutics 22-Mar-2023 Discovery Tools (Healthcare) Clinical Trials - Phase 1
BioTroy Therapeutics 07-Mar-2023 Biotechnology Pre-Clinical Trials
Ascentawits Pharmaceutical 16-Nov-2022 Pharmaceuticals Clinical Trials - Phase 2
Magpie Pharmaceuticals 15-Aug-2022 Drug Discovery Clinical Trials - General
Gigaceuticals 15-Mar-2022 Drug Discovery Generating Revenue
Tyercan 24-Jan-2022 Drug Discovery Startup
Sparx (Drug Discovery) 31-Dec-2021 Drug Discovery Clinical Trials - Phase 1
Shenzhen GSH Bio-Tech 01-Dec-2021 Later Stage VC Biotechnology Generating Revenue
China Immunotech 10-Oct-2021 Early Stage VC Biotechnology Pre-Clinical Trials
You’re viewing 10 of 72 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Shenzhen Sangel Venture Capital Exits (12)

Company Name Exit Date Exit Type Exit Size
Ultivue 09-Oct-2024 Merger/Acquisition
Refuge Biotech 03-Aug-2023
Thistory 29-Mar-2023
InnerMedical 31-Dec-2022
3D Medicines 15-Dec-2022
Bontac Bio-Engineering 25-Jun-2022
Predicine 01-Apr-2022
Sirnaomics 29-Dec-2021
Huaheng Biotech 12-Apr-2021 IPO
VersaPeutics 01-Jul-2020 Merger/Acquisition
You’re viewing 10 of 12 exits. Get the full list »

Shenzhen Sangel Venture Capital Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Shenzhen Sangel Venture Capital‘s full profile, request access.

Request a free trial

Shenzhen Sangel Venture Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Shenzhen Sangel Venture Capital FAQs

  • What is Shenzhen Sangel Venture Capital?

    Founded in 2009, Shenzhen Sangel Venture Capital is a venture capital firm headquartered in Shenzhen, China.

  • When was Shenzhen Sangel Venture Capital founded?

    Shenzhen Sangel Venture Capital was founded in 2009.

  • Where is Shenzhen Sangel Venture Capital headquartered?

    Shenzhen Sangel Venture Capital is headquartered in Shenzhen, China.

  • What is Shenzhen Sangel Venture Capital's total asset value?

    Shenzhen Sangel Venture Capital has around in total assets under management.

  • How many investments has Shenzhen Sangel Venture Capital made?

    Shenzhen Sangel Venture Capital has made 72 investments.

  • What has Shenzhen Sangel Venture Capital invested in?

    Shenzhen Sangel Venture Capital has made numerous investments in companies like OxTium, Proviva Therapeutics, and BioTroy Therapeutics within the Decision/Risk Analysis, Discovery Tools (Healthcare), and Biotechnology industries.

  • What has Shenzhen Sangel Venture Capital invested in recently?

    Shenzhen Sangel Venture Capital's latest investment was on 25-Jan-2024 in OxTium, a company within the Decision/Risk Analysis industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »